NYSEARCA:INFU - NYSE Arca - US45685K1025 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to INFU. INFU was compared to 102 industry peers in the Health Care Providers & Services industry. While INFU has a great profitability rating, there are some minor concerns on its financial health. INFU is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make INFU suitable for growth investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.06% | ||
ROE | 5.78% | ||
ROIC | 7.47% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 6.07% | ||
PM (TTM) | 2.32% | ||
GM | 53.13% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.52 | ||
Debt/FCF | 12.54 | ||
Altman-Z | 2.52 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.21 | ||
Quick Ratio | 1.83 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 42.93 | ||
Fwd PE | 17.61 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 55.09 | ||
EV/EBITDA | 7.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NYSEARCA:INFU (6/10/2025, 11:25:17 AM)
6.01
+0.06 (+1.01%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 42.93 | ||
Fwd PE | 17.61 | ||
P/S | 0.92 | ||
P/FCF | 55.09 | ||
P/OCF | 5.77 | ||
P/B | 2.29 | ||
P/tB | 2.79 | ||
EV/EBITDA | 7.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.06% | ||
ROE | 5.78% | ||
ROCE | 9.46% | ||
ROIC | 7.47% | ||
ROICexc | 7.6% | ||
ROICexgc | 8.58% | ||
OM | 6.07% | ||
PM (TTM) | 2.32% | ||
GM | 53.13% | ||
FCFM | 1.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.52 | ||
Debt/FCF | 12.54 | ||
Debt/EBITDA | 1.35 | ||
Cap/Depr | 151.51% | ||
Cap/Sales | 14.23% | ||
Interest Coverage | 250 | ||
Cash Conversion | 102.77% | ||
Profit Quality | 71.76% | ||
Current Ratio | 2.21 | ||
Quick Ratio | 1.83 | ||
Altman-Z | 2.52 |